Home > > > > > Report Detail

United States Non Invasive Prenatal Testing (NIPT) Market Size, Market Share, Insights, Growth, Trends, Opportunities, Key Players, Competitive Analysis and Forecast 2023 to 2031

Publisher Name :
Date: 01-Jun-2023
No. of pages: 150

The non-invasive prenatal testing (NIPT) market in the United States is expected to reach USD 2,653 million by 2031. The market is expected to register a CAGR of more than 13% in the forecast period.

The growth of the market depends on several factors, including the increase in the incidence of chromosomal aneuploidies in fetuses, the progress of advanced non-invasive prenatal testing products, the increasing acceptance of non-invasive prenatal testing, the growing focus on reimbursement for non-invasive prenatal testing, the rising preference for non-invasive techniques over invasive methods, and the ACOG guidelines recommending NIPT for all pregnancies regardless of risk.

The report on the non-invasive prenatal testing (NIPT) market in the United States is a comprehensive study and presentation of drivers, restraints, opportunities, demand, market size, insights, forecasts, and trends in the non-invasive prenatal testing (NIPT) market in the United States during 2019 - 2031. Furthermore, the report includes historic market data from 2019 to 2022 and forecast until 2031.

This Well-Versed and Comprehensive United States Non-Invasive Prenatal Testing (NIPT) Market Research Report 2023 is Divided into 14 Chapters:


  • Chapter 1 contains a brief description of the market under study

  • Chapter 2 describes the research methodology of the study

  • Chapter 3 identifies key trends and prospects for the U.S. non-invasive prenatal testing (NIPT) market and draws key conclusions

  • Chapter 4 analysis of average risk and high-risk non–invasive prenatal testing volume (number of tests performed) and projection through 2031

  • Chapter 5 evaluates the potential number of NIPT tests performed in the United States with eight years forecast

  • Chapter 6 discusses the market scenario for non-invasive prenatal testing (NIPT) in the United States in terms of historical market values and projections through 2031

  • Chapter 7 assessment of market potential and opportunities for this innovation-driven united states non–invasive prenatal testing market with eight years forecast

  • Chapter 8 highlights key market dynamics in the U.S. NIPT tests market, including factors driving the market, prevailing barriers, potential opportunities, and future trends. This section also includes an analysis of the impact of the driving and restraining factors

  • Chapter 9 includes a comprehensive analysis of 7 non–invasive prenatal testing comparative analysis

  • Chapter 10 characteristics of reimbursement structures in the non–invasive prenatal testing market in the United States

  • Chapter 11 detailed insights into the regulatory framework of the U.S. non–invasive prenatal testing market

  • Chapter 12 tracks competitive developments, approaches, recent industry developments, and mergers and acquisitions, collaboration, venture capital investment, distribution, exclusivity, partnership and licensing agreements.

  • Chapter 13 provides the industry landscape and detailed profiles of key companies operating in the non–invasive prenatal testing market in the United States. The companies have been profiled based on their key facts, business description, products and services, current NIPT test portfolio, and key developments.

  • Chapter 14 i.e. the appendix contains a brief overview of the company, a glossary, contact information, and the disclaimer section.


Key Players in the United States Non–Invasive Prenatal Testing Market are Listed Below:


  • Illumina, Inc.

  • Natera, Inc.

  • Quest Diagnostics

  • Myriad Genetics, Inc.

  • Centogene

  • GenPath

  • PerkinElmer

  • Yourgene Health

  • Invitae Corporation

  • Agilent Technologies

  • Ariosa Diagnostics (Roche)

  • Laboratory Corporation of America Holdings(Labcorp)


The Most Important Questions are Answered in this Current 2023 Report:


  • What is the current scenario of the non-invasive prenatal testing market in the United States?

  • What is the total market size for non-invasive prenatal testing in the United States and what are the projections (through 2031) for this market?

  • How large is the market for noninvasive prenatal testing in the United States?

  • Which is the top non-invasive prenatal test available in the united states?

  • How has the potential market performed so far and how will it perform in the coming years?

  • How many NIPT tests are being performed in the united states during 2019 – 2031?

  • What is the market size of the average risk NIPT tests in the united states?

  • What is the market size of the high-risk NIPT tests in the united states?

  • What are the key marketed NIPT tests available in the united states?

  • What are the major drivers of the united states non–invasive prenatal testing market?

  • What are the major inhibitors of the united states non–invasive prenatal testing market?

  • What is the reimbursement pattern in the united states non–invasive prenatal testing market?

  • What is the regulatory framework in the united states non–invasive prenatal testing market? 


What are the major deals and agreement happenings in the united states non–invasive prenatal testing market?


  • What companies offer NIPT tests in the united states?

  • Who are the top market players? What are their happenings, current developments, and scenarios?

  • How is the market predicted to develop in the future?

  • What is the degree of competition in the industry?

United States Non Invasive Prenatal Testing (NIPT) Market Size, Market Share, Insights, Growth, Trends, Opportunities, Key Players, Competitive Analysis and Forecast 2023 to 2031

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. United States Actual Non–Invasive Prenatal Testing Volume (Number of Tests Performed) and Forecast (2019 - 2031)
4.1 Average Risk Actual NIPT Test Volume (Number of Tests Performed) and Forecast
4.2 High-Risk Actual NIPT Test Volume (Number of Tests Performed) and Forecast

5. United States Potential Non–Invasive Prenatal Testing Volume (Number of Tests Performed) and Forecast (2019 - 2031)
5.1 Average Risk Potential NIPT Test Volume (Number of Tests Performed) and Forecast
5.2 High-Risk Potential NIPT Test Volume (Number of Tests Performed) and Forecast

6. United States Actual Non–Invasive Prenatal Testing Market Size and Forecast (2019 - 2031)
6.1 Average Risk Actual NIPT Test Market Size and Forecast
6.2 High-Risk Actual NIPT Test Market Size and Forecast

7. United States Potential Non–Invasive Prenatal Testing Market Size and Forecast (2019 - 2031)
7.1 Average Risk Potential NIPT Test Market Size and Forecast
7.2 High-Risk Potential NIPT Test Market Size and Forecast

8. United States Non–Invasive Prenatal Testing Market Growth Drivers and Challenges
8.1 Key Market Growth Drivers
8.2 Key Market Challenges

9. Non–Invasive Prenatal Testing Comparative Analysis

10. Reimbursement Environment of the United States Non-Invasive Prenatal Testing

11. Regulation Framework of the United States Non-Invasive Prenatal Testing

12. Major Deals and Agreements in the Non–Invasive Prenatal Testing Market
12.1 Collaboration Deals
12.2 Venture Capital Investment
12.3 Mergers and Acquisitions
12.4 Exclusive Agreement
12.5 Licensing Agreement
12.6 Distribution Agreement
12.7 Partnership Deals

13. Key Companies Analysis
13.1 Laboratory Corporation of America Holdings
13.1.1 Business Overview
13.1.2 Product Outlook
13.1.3 Key Developments
13.2 Yourgene Health
13.2.1 Business Overview
13.2.2 Product Outlook
13.2.3 Key Developments
13.3 Ariosa Diagnostics (Roche)
13.3.1 Business Overview
13.3.2 Product Outlook
13.3.3 Key Developments
13.4 Illumina, Inc.
13.4.1 Business Overview
13.4.2 Product Outlook
13.4.3 Key Developments
13.5 Natera,Inc.
13.5.1 Business Overview
13.5.2 Product Outlook
13.5.3 Key Developments
13.6 Quest Diagnostics
13.6.1 Business Overview
13.6.2 Product Outlook
13.6.3 Key Developments
13.7 Myriad Genetics, Inc.
13.7.1 Business Overview
13.7.2 Product Outlook
13.7.3 Key Developments
13.8 Centogene
13.8.1 Business Overview
13.8.2 Product Outlook
13.8.3 Key Developments
13.9 Invitae Corporation
13.9.1 Business Overview
13.9.2 Product Outlook
13.9.3 Key Developments
13.10 GenPath
13.10.1 Business Overview
13.10.2 Product Outlook
13.10.3 Key Developments
13.11 PerkinElmer
13.11.1 Business Overview
13.11.2 Product Outlook
13.11.3 Key Developments
13.12 Agilent Technologies
13.12.1 Business Overview
13.12.2 Product Outlook
13.12.3 Key Developments

14. Appendix
14.1 About DPI Research
14.2 Glossary of Terms

List of Figures:

Figure 2 1: United States Actual NIPT Test Volume (Thousand),2019 – 2022
Figure 2 2: United States Actual NIPT Test Volume Forecast (Thousand),2023 – 2031
Figure 2 3: United States Average Risk Actual NIPT Test Volume (Thousand),2019 – 2022
Figure 2 4: United States Average Risk Actual NIPT Test Volume Forecast (Thousand),2023 – 2031
Figure 2 5: United States High-Risk Actual NIPT Test Volume (Thousand),2019 – 2022
Figure 2 6: United States High-Risk Actual NIPT Test Volume Forecast (Thousand),2023 – 2031
Figure 3 1: United States Potential NIPT Test Volume (Thousand),2019 – 2022
Figure 3 2: United States Potential NIPT Test Volume Forecast (Thousand),2023 – 2031
Figure 3 3: United States Average Risk Potential NIPT Test Volume (Thousand),2019 – 2022
Figure 3 4: United States Average Risk Potential NIPT Test Volume Forecast (Thousand),2023 – 2031
Figure 3 5: United States High-Risk Potential NIPT Test Volume (Thousand),2019 – 2022
Figure 3 6: United States High-Risk Potential NIPT Test Volume Forecast (Thousand),2023 – 2031
Figure 4 1: United States Actual NIPT Test Market Size (Million US$),2019 – 2022
Figure 4 2: United States Actual NIPT Test Market Size Forecast (Million US$),2023 – 2031
Figure 4 3: United States Average Risk Actual NIPT Test Market Size (Million US$),2019 – 2022
Figure 4 4: United States Average Risk Actual NIPT Test Market Size Forecast (Million US$),2023 – 2031
Figure 4 5: United States High-Risk Actual NIPT Test Market Size (Million US$),2019 – 2022
Figure 4 6: United States High-Risk Actual NIPT Test Market Size Forecast (Million US$),2023 – 2031
Figure 5 1: United States Potential NIPT Test Market Size (Million US$),2018 – 2021
Figure 5 2: United States Potential NIPT Test Market Size Forecast (Million US$),2022 – 2030
Figure 5 3: United States Average Risk Potential NIPT Test Market Size (Million US$),2019 – 2022
Figure 5 4: United States Average Risk Potential NIPT Test Market Size Forecast (Million US$),2023 – 2031
Figure 5 5: United States High-Risk Potential NIPT Test Market Size (Million US$),2019 – 2022
Figure 5 6: United States High-Risk Potential NIPT Test Market Size Forecast (Million US$),2023 – 2031

List of Tables:

Table 6 1: Maternal Age at Delivery and Risk of Down Syndrome
Table 7 1: Non–Invasive Prenatal Testing – Comparative Tests Analysis
Table 10 1: Collaboration Deals in the Non–Invasive Prenatal Testing Market
Table 10 2: Venture Capital Investment in the Non–Invasive Prenatal Testing Market
Table 10 3: Merger & Acquisition in the Non–Invasive Prenatal Testing Market
Table 10 4: Exclusive Agreement in the Non–Invasive Prenatal Testing Market
Table 10 5: Licensing Agreement in the Non–Invasive Prenatal Testing Market
Table 10 6: Distribution Agreement in the Non–Invasive Prenatal Testing Market
Table 10 7: Partnership Deals in the Non–Invasive Prenatal Testing Market

  • Global Drugs for Vulvovaginal Candidiasis Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 119
    According to our LPI (LP Information) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at US$ 798.8 million in 2023. With growing demand in downstream market, the Drugs for Vulvovaginal Candidiasis is forecast to a readjusted size of US$ 890 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Drugs for Vulvovaginal Candidiasis market. Drugs for Vulvovaginal Candidiasis are expected t......
  • Global Bacterial Vaginosis Drug Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132
    According to our LPI (LP Information) latest study, the global Bacterial Vaginosis Drug market size was valued at US$ 896.6 million in 2023. With growing demand in downstream market, the Bacterial Vaginosis Drug is forecast to a readjusted size of US$ 1111.1 million by 2030 with a CAGR of 3.1% during review period. The research report highlights the growth potential of the global Bacterial Vaginosis Drug market. Bacterial Vaginosis Drug are expected to show stable growth in the future ma......
  • Global Contraceptives Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 141
    According to our LPI (LP Information) latest study, the global Contraceptives market size was valued at US$ 1870.3 million in 2023. With growing demand in downstream market, the Contraceptives is forecast to a readjusted size of US$ 2237.4 million by 2030 with a CAGR of 2.6% during review period. The research report highlights the growth potential of the global Contraceptives market. Contraceptives are expected to show stable growth in the future market. However, product differentiation,......
  • Global Drugs for Vulvovaginal Candidiasis Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 108
    According to our (Global Info Research) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at USD 840.2 million in 2023 and is forecast to a readjusted size of USD 928.4 million by 2030 with a CAGR of 1.4% during review period. The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cu......
  • Global Menopausal Hot Flashes Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 99
    Market Overview of Global Menopausal Hot Flashes market: According to our latest research, the global Menopausal Hot Flashes market looks promising in the next 5 years. As of 2022, the global Menopausal Hot Flashes market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Hot flashes during menopause are symptoms of menopause. They refer to the warmth that occurs during the transition period of ......
  • Global Bacterial Vaginosis Drug Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 139
    Report Overview: This report studies the Bacterial Vaginosis Drug market, Bacterial Vaginosis Drug is used for the treatment of Bacterial Vaginosis (BV), which also known as vaginal bacteriosis or Gardnerella vaginitis, a disease of the vagina caused by excessive bacteria. This report includes metronidazole, clindamycin drug and other drugs. The Global Bacterial Vaginosis Drug Market Size was estimated at USD 916.50 million in 2022 and is projected to reach USD 1127.18 million by 202......
  • Global Drugs for Vulvovaginal Candidiasis Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 122
    Report Overview: The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cure rates in excess of 80%. The only oral azole agent approved for this indication by the US Food and Drug Administration (FDA) is fluconazole, which also achieves a high cure rate. Therapeutic concentrations are found in vaginal secretions for a......
  • Global Bacterial Vaginosis Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 108
    Market Overview of Global Bacterial Vaginosis Drug market: According to our latest research, the global Bacterial Vaginosis Drug market looks promising in the next 5 years. As of 2022, the global Bacterial Vaginosis Drug market was estimated at USD 972.77 million, and it's anticipated to reach USD 1215.68 million in 2028, with a CAGR of 3.79% during the forecast years. Bacterial vaginosis (BV), also known as bacterial vaginosis, non-specific vaginitis is a disease that occurs......
  • Global Tocolysis Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 30-Nov-2023        Price: US 3380 Onwards        Pages: 123
    Market Overview of Global Tocolysis Drugs market: According to our latest research, the global Tocolysis Drugs market looks promising in the next 5 years. As of 2022, the global Tocolysis Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Tocolytics are medications used to suppress premature labor. Tocolytic therapy is provided when delivery would result in premature birth, postponi......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs